- Walgreens is a major pharmaceutical retailer that provides therapeutic, health, and beauty products globally that has recently experienced declines from the global healthcare crisis over the last year.
- However, Walgreens is expected to see strong recovery due to its store expansions, streamlining its business, and cost-cutting measures. Furthermore, Walgreens currently has an appealing valuation and dividend yield.
- Interestingly, competitor CVS has performed better over the last year than Walgreens and is expected to have comparable growth going forward, though it currently has a lower dividend yield.
- Taken together, I believe that Walgreens could make an appealing dividend investment, especially as its fundamentals continue to improve. CVS also performed well and may also warrant further investigation.
For further details see:
Walgreens: A Pharmaceutical Retailer Dividend Aristocrat Worth Watching